|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 烧伤治疗历史的回顾与展望显示文摘机体损伤涉及临床医学多学科,烧伤为平时和战时常见的一种组织损伤,它的修复包括维持机体的内环境稳定和不同深度的组织损伤后的修复全过程。近50年来,我国现代烧伤临床和研究发展迅速,业绩显著。虽然有不少创新成就,但由于对外交流还不够,尚未达到足够影响力,有些工作还不被人所知,我们应当一方面加强对外学术交流,扩大影响,另一方面,随时关注国际动态,做到知己知彼。为了使我国广大临床工作者系统了解美国烧伤临床和研究的概况,本刊组织了数位专家翻译由美国著名的烧伤专家David Heradon主编,近百余位专家撰写的Total Burn Care(第二版)2002年出版的美国最权威的烧伤治疗一书,将在本刊连续刊登,供同道们参考,该文有许多值得我们思考的地方。学诸专家之长,结合我国国情,走自己的创新之路,把我国烧伤治疗和研究推向新水平,为丰富国际烧伤医学宝库而奋斗。 | Steven Thomas Roberte Barrow David N Herndon 孙永华 | 2007 | 中华损伤与修复杂志(电子版)2007，2，3： | 6 |
| 2 | 烧伤治疗的历史显示文摘烧伤的治疗已有超过3500年的历史。在尼安德特人洞穴里发现的壁画是最早的直接性证据。对于烧伤的治疗,公元前1500年,埃及铁匠的纸莎草纸文件材料中提到使用树脂和蜂蜜混合成的药膏来治疗;在公元前600年,中国人使用的是酊和从茶叶中榨取的汁;之后将近两百年, | 张杨杨 贾赤宇 Barrow RE Herndon DN | 2012 | 中华损伤与修复杂志(电子版)2012，7，4： | 4 |
| 3 | Early fluid resuscitation improves outcomes in severely burned children显示文摘 | Robert E. Barrow Marc G. Jeschke David N. Herndon | 2000 | Resuscitation2000，，2： | 2 |
| 4 | Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer显示文摘 | Brandon A. Howard Zhong Zheng Michael J. Campa Michael Z. Wang Anupama Sharma Eric Haura James E. Herndon Michael C. Fitzgerald Gerold Bepler Edward F. Patz | 2004 | Lung Cancer2004，，： | 2 |
| 5 | 重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls. | Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD | 2018 | 中华神经外科疾病研究杂志2018，17，4： | 2 |
| 6 | Pulmonary vein diameter,cross-sectional area,and shape:CT analysis显示文摘 | Kim YH Marom EM Herndon JE | 2005 | Radiology2005，235，1： | 1 |
| 7 | Randomized phase Ⅱ study of cisplatin with gemcitabin or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage ⅢB Non-small Cell Lung Cancer:cancer and leukemia group B study 9431显示文摘 | Vokes EE Herndon JE Crawford J | 2002 | J Clin Oncol2002，20，： | 1 |
| 8 | Improved survival instageⅢnon small cell lung cancer:seven-year follow up ofCancer and Leukemia Group B(CALGB)8433 trial显示文摘 | Dillman RO Herndon J Seagren SL | 1996 | J NatlCancer Inst1996，88，17： | 1 |
| 9 | Central corneal thickness as a risk factor for advanced glaucoma damage显示文摘 | Herndon LW Weizer JS Stinnett SS | 2004 | Arch Ophthalmol2004，122，1： | 1 |
| 10 | Fat embolism:evolution of histopathological changes in the rat lung显示文摘 | Mclff TE Poisner AM Herndon B | | 0，，02： | 1 |
| 11 | Insulin treatment im- proves the systemic inflammatory reaction to severe trauma 显示文摘 | JeschkeM G Klein D Herndon DN | 2004 | Ann Surg2004，239，4： | 1 |
| 12 | Transplanted acellular allograft dermal matrix显示文摘 | FLIVESEY S A HERNDON D N HOLLYOAK M A | 1995 | Transplantation1995，60，： | 1 |
| 13 | The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma显示文摘 | Ahuja V Coleman RE Herndon J | 1998 | Cancer1998，83，： | 1 |
| 14 | Reversal of catabolism by beta-blockade after severe burns显示文摘 | Herndon DN Hart DW Wolf SE | 2001 | N Engl J Med2001，345，17： | 1 |
| 15 | Randomized phase Ⅲ intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small cell lung cancer: Cancer and Leukemia Group B Trial 9732显示文摘 | Niell HB Herndon JE 2nd Miller AA | 2005 | J Clin Oncol2005，23，： | 1 |
| 16 | Mycoplasma ovipneumoniae can predispose bighorn sheepto fatal Mannheimia haemolytica pneumonia 显示文摘 | Dassanayake R P Shanthalingam S Herndon C N? | 2010 | Veterina-ry Microbiology2010，145，： | 1 |
| 17 | Bevacizumab plus irinotecan in recurrent glioblastoma multiforme显示文摘 | Vredenburgh JJ Desjardins A Herndon JE | 2007 | J Clin Oncol2007，25，30： | 1 |
| 18 | Reversal of catabolism by beta-blockade after severe burns显示文摘 | Herndon DN Hart DW Wolf SE | 2001 | N Engl J Med2001，345，17： | 1 |
| 19 | Does High Public Debt Consistently Stifle Economic Growth?A Critique of Reinhart and Rogoff显示文摘 | Herndon T Ash M Pollin R | 2014 | Cambridge Journal of Economics2014，38，2： | 1 |
| 20 | The factor age and the recovery of severely burned children 显示文摘 | PxTkora R Herndon DN Jeschke MG | 2008 | Burns2008，34，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员